Cargando…

Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells

We have found that when muscle-derived stem cells (MDSCs) are implanted into a variety of tissues only a small fraction of the donor cells can be found within the regenerated tissues and the vast majority of cells are host derived. This observation has also been documented by other investigators usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharaibeh, Burhan, Lavasani, Mitra, Cummins, James H, Huard, Johnny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219062/
https://www.ncbi.nlm.nih.gov/pubmed/21745421
http://dx.doi.org/10.1186/scrt72
_version_ 1782216783975940096
author Gharaibeh, Burhan
Lavasani, Mitra
Cummins, James H
Huard, Johnny
author_facet Gharaibeh, Burhan
Lavasani, Mitra
Cummins, James H
Huard, Johnny
author_sort Gharaibeh, Burhan
collection PubMed
description We have found that when muscle-derived stem cells (MDSCs) are implanted into a variety of tissues only a small fraction of the donor cells can be found within the regenerated tissues and the vast majority of cells are host derived. This observation has also been documented by other investigators using a variety of different stem cell types. It is speculated that the transplanted stem cells release factors that modulate repair indirectly by mobilizing the host's cells and attracting them to the injury site in a paracrine manner. This process is loosely called a 'paracrine mechanism', but its effects are not necessarily restricted to the injury site. In support of this speculation, it has been reported that increasing angiogenesis leads to an improvement of cardiac function, while inhibiting angiogenesis reduces the regeneration capacity of the stem cells in the injured vascularized tissues. This observation supports the finding that most of the cells that contribute to the repair process are indeed chemo-attracted to the injury site, potentially through host neo-angiogenesis. Since it has recently been observed that cells residing within the walls of blood vessels (endothelial cells and pericytes) appear to represent an origin for post-natal stem cells, it is tempting to hypothesize that the promotion of tissue repair, via neo-angiogenesis, involves these blood vessel-derived stem cells. For non-vascularized tissues, such as articular cartilage, the regenerative property of the injected stem cells still promotes a paracrine, or bystander, effect, which involves the resident cells found within the injured microenvironment, albeit not through the promotion of angiogenesis. In this paper, we review the current knowledge of post-natal stem cell therapy and demonstrate the influence that implanted stem cells have on the tissue regeneration and repair process. We argue that the terminal differentiation capacity of implanted stem cells is not the major determinant of the cells regenerative potential and that the paracrine effect imparted by the transplanted cells plays a greater role in the regeneration process.
format Online
Article
Text
id pubmed-3219062
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32190622012-07-08 Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells Gharaibeh, Burhan Lavasani, Mitra Cummins, James H Huard, Johnny Stem Cell Res Ther Review We have found that when muscle-derived stem cells (MDSCs) are implanted into a variety of tissues only a small fraction of the donor cells can be found within the regenerated tissues and the vast majority of cells are host derived. This observation has also been documented by other investigators using a variety of different stem cell types. It is speculated that the transplanted stem cells release factors that modulate repair indirectly by mobilizing the host's cells and attracting them to the injury site in a paracrine manner. This process is loosely called a 'paracrine mechanism', but its effects are not necessarily restricted to the injury site. In support of this speculation, it has been reported that increasing angiogenesis leads to an improvement of cardiac function, while inhibiting angiogenesis reduces the regeneration capacity of the stem cells in the injured vascularized tissues. This observation supports the finding that most of the cells that contribute to the repair process are indeed chemo-attracted to the injury site, potentially through host neo-angiogenesis. Since it has recently been observed that cells residing within the walls of blood vessels (endothelial cells and pericytes) appear to represent an origin for post-natal stem cells, it is tempting to hypothesize that the promotion of tissue repair, via neo-angiogenesis, involves these blood vessel-derived stem cells. For non-vascularized tissues, such as articular cartilage, the regenerative property of the injected stem cells still promotes a paracrine, or bystander, effect, which involves the resident cells found within the injured microenvironment, albeit not through the promotion of angiogenesis. In this paper, we review the current knowledge of post-natal stem cell therapy and demonstrate the influence that implanted stem cells have on the tissue regeneration and repair process. We argue that the terminal differentiation capacity of implanted stem cells is not the major determinant of the cells regenerative potential and that the paracrine effect imparted by the transplanted cells plays a greater role in the regeneration process. BioMed Central 2011-07-08 /pmc/articles/PMC3219062/ /pubmed/21745421 http://dx.doi.org/10.1186/scrt72 Text en Copyright ©2011 BioMed Central Ltd
spellingShingle Review
Gharaibeh, Burhan
Lavasani, Mitra
Cummins, James H
Huard, Johnny
Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells
title Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells
title_full Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells
title_fullStr Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells
title_full_unstemmed Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells
title_short Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells
title_sort terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219062/
https://www.ncbi.nlm.nih.gov/pubmed/21745421
http://dx.doi.org/10.1186/scrt72
work_keys_str_mv AT gharaibehburhan terminaldifferentiationisnotamajordeterminantforthesuccessofstemcelltherapycrosstalkbetweenmusclederivedstemcellsandhostcells
AT lavasanimitra terminaldifferentiationisnotamajordeterminantforthesuccessofstemcelltherapycrosstalkbetweenmusclederivedstemcellsandhostcells
AT cumminsjamesh terminaldifferentiationisnotamajordeterminantforthesuccessofstemcelltherapycrosstalkbetweenmusclederivedstemcellsandhostcells
AT huardjohnny terminaldifferentiationisnotamajordeterminantforthesuccessofstemcelltherapycrosstalkbetweenmusclederivedstemcellsandhostcells